In the tissue engineering industry there is a lot of discussion around the complexities of seeding adherent cells, the best modes for generating vascularized scaffolds, the challenges associated with the packaging and transport of tissue-engineered medical products (TEMPs), and how to get your product to market quickly.
Biomedical engineers grow personalized tissue transplants for heart, spinal cord, and brain from patients’ own fatty cells.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Korean researchers find simpler way to discover which bacteria can produce the highest concentration of a valuable chemical intermediate.
Dr. Christopher Jewell of the University of Maryland joins the ASME TechCast podcast to discuss the emerging field of biomaterials research and development and the different opportunities it offers cross-disciplinary engineers.
A new type of surface coating made from photosensitizer molecules kills viruses, bacteria, and other pathogens when applied to consumer and medical products.
DNA delivered to cells via electrical pulses was first explored for creating new vaccines and is now being tested in the lab to produce disease-fighting proteins.
Platelet BioGenesis built a device that makes platelets. The process could revolutionize blood transfusions and cancer treatment.
In episode 2 of ASME TechCast, we explore the communication gap that often exists between engineers and their colleagues, especially clinicians and others in the biomedical industry. We also discuss the new lexicon that members of the Alliance of Advanced Biomedical Engineering (AABME.org) are rolling out to help solve that problem.
Researchers moved closer to solving problems with treating heart disease by developing ways to build tissues and parts of a human heart using human stem cells.
Engineers have developed a new process of 3D bioprinting tissues that uses multiple cell-based inks to create more realistic structures in less time than previous methods.
Cell therapy manufacturing is a new discipline where production of adult and pluripotent stem cell types are required for cell therapies. Several hundreds of clinical trials with adult mesenchymal stem cells for therapies such as auto-immune diseases, bone, cartilage repair and stroke are looking promising. For the pluripotent stem cell therapies, retinal pigment epithelial cells, pancreatic islet progenitors and neurons are being applied for treating blindness, diabetes and Parkinson’s disease in early stage clinical trials.
Scientists and bioengineers are warming up to cryogenic electron microscopy (cryo-EM), an ultra-low-temperature technique for visualizing the atomic-level inner workings of human cells and other applications.
It’s no secret that most biomedical firms today use modeling to make research and development decisions. What remains to be seen is how to take modeling, within companies and among regulatory agencies, to the next level.
Medical device makers lag other industries in their use of computer models. One of the big issues discussed at Visualize MED is how much can researchers, regulators, and engineers trust their models and simulation?